Hossein Jadvar presents on the use of sodium fluoride and radium-223 as a theranostic pair in the treatment of patients with metastatic prostate cancer. ¹⁸F-sodium fluoride has experienced a renaissance in the management of neuroendocrine tumors and prostate cancer. Dr. Jadvar presents this information during the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Biographies:

Hossein Jadvar, MD, Ph.D., MPH, MBA, Associate Professor of Radiology, Associate Professor of Biomedical Engineering, The University of Southern California, Previous President of the Society of Nuclear Medicine.

Related Content:

Watch: Radium 223 Dichloride Use in Patients with Castrate Resistant Prostate Cancer - Hossein Jadvar

Read: 18F-NaF/223RaCl2 theranostics in metastatic prostate cancer: treatment response assessment and prediction of outcome.